G. Hazlehurst

Blood product support in patients undergoing chemotherapy and autologous or allogeneic bone marrow transplantation for haematological malignancies.

H. Prentice, A. Hoffbrand, A. Mehta, 2008, Clinical and laboratory haematology.

Endogenously generated activated killer cells circulate after autologous and allogeneic marrow transplantation but not after chemotherapy.

H. Heslop, H. Drexler, H. Drexler, 1989, Blood.

Haemolysis after T-cell depleted bone marrow transplantation involving minor AB0 incompatibility.

H. Prentice, M. Brenner, S. Knowles, 2009, Scandinavian journal of haematology.

Possible mechanism of selective killing of myeloid leukemic blast cells by lymphokine-activated killer cells.

H. Heslop, P. Veys, H. Prentice, 1991, Blood.

A and B blood group antigen expression on mixed colony cells and erythroid precursors: relevance for human allogeneic bone marrow transplantation

A. Hoffbrand, R. Michalevicz, H. Blacklock, 1984, British journal of haematology.

ABO-INCOMPATIBLE BONE-MARROW TRANSPLANTATION: REMOVAL OF RED BLOOD CELLS FROM DONOR MARROW AVOIDING RECIPIENT ANTIBODY DEPLETION

H. Prentice, A. Hoffbrand, D. Ma, 1982, The Lancet.

DEVELOPMENT OF ‘AUTO ANTI‐A1 ANTIBODIES’ FOLLOWING ALLOIMMUNIZATION IN AN A2 RECIPIENT

M. Contreras, S. Armitage, G. Hazlehurst, 1984 .

Leucodepletion for transmissible spongiform encephalopathies

G. Hazlehurst, A. Jewell, C.ST Romaine, 2004, British journal of biomedical science.

Acute transplant rejection induced by blood transfusion reaction to the Kidd blood group system.

Z. Varghese, M. Contreras, E. Kingdon, 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Development of ‘auto‐anti‐A1 antibodies’ following alloimmunization in an A2 recipient

S. Armitage, G. Hazlehurst, Marcela Contreras, 1983, British journal of haematology.